Barbara Muzii
Milan, 20158, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Burden and Characteristics of Respiratory Syncytial Virus-Associated Bronchiolitis in Hospitalized Infants in Italy: A Systematic Review.
Journal: Immunity, inflammation and disease
Published: April 30, 2025
Cost-Effectiveness Analysis of Nirsevimab for the Prevention of Respiratory Syncytial Virus among Italian Infants.
Journal: Clinical drug investigation
Published: March 25, 2025
Respiratory Syncytial Virus associated hospitalisations in children up to 6 years of age in Italy: a systematic review.
Journal: Annali di igiene : medicina preventiva e di comunita
Published: November 11, 2024
Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in Italy.
Journal: Global & regional health technology assessment
Published: June 27, 2024
Costs and healthcare utilisation due to respiratory syncytial virus disease in paediatric patients in Italy: a systematic review.
Journal: Public health
Published: September 28, 2023
Clinical and economic burden of respiratory syncytial virus in children aged 0-5 years in Italy.
Journal: Italian journal of pediatrics
Published: September 19, 2023
Cost-effectiveness for high dose quadrivalent versus the adjuvanted quadrivalent influenza vaccine in the Italian older adult population.
Journal: Frontiers in public health
Published: April 04, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026